AURKB activates EMT through PI3K/AKT signaling axis to promote ICC progression

被引:9
|
作者
Ma, Peng [1 ]
Hao, Ying [1 ]
Wang, Wei [1 ]
Zhang, Yue-Feng [1 ]
Yu, Kai-Huan [1 ]
Wang, Wei-Xing [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Hepatobiliary Surg, Wuhan 430060, Hubei, Peoples R China
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; CHOLANGIOCARCINOMA; SURVIVAL;
D O I
10.1007/s12672-023-00707-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrahepatic cholangiocarcinoma (ICC) is a fatal disease and the molecular mechanism of its progression remains unknown. Aurora Kinase B (AURKB) is a central regulator of chromosome separation and cytokinesis and is abnormally expressed in a variety of cancer cells. This research aimed to explore the effect of AURKB in occurrence and metastasis of ICC. We found that AURKB showed a progressive up-regulation pattern from normal bile duct tissue to ICC with high invasion. Our data showed that AURKB significantly promoted ICC cell proliferation, induced epithelial-mesenchymal transition (EMT), migration and invasion through gain- and loss- of function experiments. In vivo results consistently showed that AURKB up-regulation not only promoted tumor growth, but also promoted tumor metastasis. Importantly, we discovered that AURKB regulates the expressions of EMT-related genes via PI3K/AKT signaling axis. Herein, our results suggest that AURKB induced EMT through the activation of PI3K/AKT signaling pathway is critical to the progression of ICC, which may be a prospective therapeutic treatment for overcoming ICC metastasis and progression.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies
    David Barrett
    Valerie I. Brown
    Stephan A. Grupp
    David T. Teachey
    Pediatric Drugs, 2012, 14 (5) : 299 - 316
  • [22] Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies
    Barrett, David
    Brown, Valerie I.
    Grupp, Stephan A.
    Teachey, David T.
    PEDIATRIC DRUGS, 2012, 14 (05) : 299 - 316
  • [23] LACTB Regulates PIK3R3 to Promote Autophagy and Inhibit EMT and Proliferation Through the PI3K/AKT/mTOR Signaling Pathway in Colorectal Cancer
    Xu, Wei
    Yu, Minhao
    Qin, Jun
    Luo, Yang
    Zhong, Ming
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5181 - 5200
  • [24] HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway
    Liu, Wenda
    Xia, Kezhou
    Huang, Xinghan
    Wei, Zhun
    Wei, Zicheng
    Wang, Xingyu
    Xiong, Chen
    Guo, Weichun
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [25] Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathway
    Qishuai Chen
    Tongtong Zhang
    Bingjun Li
    Zhenguo Zhu
    Xiaomin Ma
    Yun Zhang
    Linchuan Li
    Jiankang Zhu
    Guangyong Zhang
    European Journal of Medical Research, 29
  • [26] USP7 promotes hepatoblastoma progression through activation of PI3K/AKT signaling pathway
    Ye, Mujie
    He, Jiajun
    Zhang, Jingjing
    Liu, Baihui
    Liu, Xiangqi
    Xie, Lulu
    Wei, Meng
    Dong, Rui
    Li, Kai
    Ma, Duan
    Dong, Kuiran
    CANCER BIOMARKERS, 2021, 31 (02) : 107 - 117
  • [27] Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathway
    Chen, Qishuai
    Zhang, Tongtong
    Li, Bingjun
    Zhu, Zhenguo
    Ma, Xiaomin
    Zhang, Yun
    Li, Linchuan
    Zhu, Jiankang
    Zhang, Guangyong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
  • [28] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [29] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Ye, Yanqing
    Liu, Maosheng
    Wu, Fengfei
    Ou, Shiyu
    Wang, Weidong
    Fei, Jieying
    Xie, Fang
    Bai, Lan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [30] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Yanqing Ye
    Maosheng Liu
    Fengfei Wu
    Shiyu Ou
    Weidong Wang
    Jieying Fei
    Fang Xie
    Lan Bai
    European Journal of Medical Research, 28